Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields
Authors not listed · 2005
Power line frequency EMF exposure may make breast cancer cells resistant to tamoxifen treatment.
Plain English Summary
German researchers exposed breast cancer cells to 50 Hz electromagnetic fields (the same frequency as power lines) and found that EMF exposure made the cells more resistant to tamoxifen, a common breast cancer drug. The effect was strongest at 1.2 microTesla field strength, suggesting that power-frequency EMF exposure could interfere with cancer treatment effectiveness.
Why This Matters
This study reveals a troubling intersection between EMF exposure and cancer treatment that deserves serious attention. The researchers found that 50 Hz electromagnetic fields - the exact frequency of our electrical power grid - can make breast cancer cells resistant to tamoxifen, one of the most widely prescribed cancer medications. The field strength that produced maximum interference (1.2 microTesla) is well within the range of everyday exposures near electrical appliances, power lines, and wiring. What makes this particularly concerning is that breast cancer patients undergoing treatment may be unknowingly exposed to EMF levels that could undermine their therapy. While this was a laboratory study on isolated cells, it adds to growing evidence that EMF exposure may not just increase cancer risk but could also interfere with treatment once cancer develops. The timing couldn't be more relevant as both breast cancer rates and our EMF exposures have risen dramatically since World War II.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{induction_of_tamoxifen_resistance_in_breast_cancer_cells_by_elf_electromagnetic_fields_ce2217,
author = {Unknown},
title = {Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields},
year = {2005},
doi = {10.1016/J.BBRC.2005.08.243},
}